| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Apr 4, 2017 | Apr 5, 2017 | Oruka Therapeutics, Inc. | CEO | Sell | 52.5 | -720 | -0.82% | ✓ | $1.7K |
| Feb 28, 2017 | Mar 1, 2017 | Oruka Therapeutics, Inc. | CEO | Sell | 52.5 | -763 | -0.87% | ✓ | $2K |
| Sep 20, 2016 | Sep 21, 2016 | Oruka Therapeutics, Inc. | CEO | Sell | 46.3 | -1,972 | -2.19% | ✓ | $5.7K |
| Apr 5, 2016 | Apr 6, 2016 | Oruka Therapeutics, Inc. | Officer | Sell | 52.5 | -724 | -0.80% | ✓ | $2.5K |
| Mar 1, 2016 | Mar 2, 2016 | Oruka Therapeutics, Inc. | Officer | Sell | 52.5 | -752 | -0.82% | ✓ | $2.6K |
| Sep 18, 2015 | Sep 21, 2015 | Oruka Therapeutics, Inc. | Officer | Sell | 48.8 | -1,809 | -1.94% | ✓ | $11.5K |
| Mar 2, 2015 | Mar 2, 2015 | Oruka Therapeutics, Inc. | Officer | Sell | 52.5 | -5,446 | -0.83% | ✓ | $3.9K |
| Sep 18, 2014 | Sep 19, 2014 | Oruka Therapeutics, Inc. | CEO | Sell | 45.0 | -13,853 | -2.22% | ✓ | $18K |
| Jan 25, 2013 | Jan 28, 2013 | Oruka Therapeutics, Inc. | CEO | Buy | 97.5 | +1,069,290 | 95.94% | ✗ | $500K |